Flu & RSV Infections

The Vivalytic Flu & RSV Test is an essential diagnostic tool for rapidly detecting and differentiating between SARS-CoV-2, Influenza A, Influenza B, and RSV. As these viruses often present overlapping symptoms, the test is crucial for targeted patient management and treatment, especially in settings where quick and accurate differentiation is critical.

This test is an ideal tool for healthcare providers to improve infection control, risk assessment, and patient care amidst the challenges posed by these common respiratory viruses.

This test simultaneously tests for SARS-CoV-2 (E gene and N gene), Influenza A, Influenza B, and RSV, providing a comprehensive respiratory virus profile. It is designed to facilitate rapid triage and supports targeted treatment strategies for these viral infections.

With its Real-Time PCR technology, the test offers fast and reliable results, aiding in quick and accurate diagnosis. Results are delivered in less than 1 hour, enabling swift clinical treatment decisions.

The Vivalytic Flu & RSV Test is a cost-effective solution that combines multiple tests into one. It addresses the challenges of respiratory infections at the point of care by reducing costs and providing a flexible solution compatible with nasopharyngeal or oropharyngeal swab samples.

Following the test, healthcare professionals should use the results to guide their clinical decisions, including infection control measures and patient treatment strategies. This test plays a vital role in enhancing patient care by providing accurate information for effective management of respiratory infections.